Mika AI vs Vero: phone apps, SOC 2 Type II, and a free plan
Vero has iPhone and Android apps, is SOC 2 Type II certified, and keeps a free plan after the trial. Pay monthly or yearly.
Used by clinicians at Cleveland Clinic, Harvard Medical School, Johns Hopkins School of Medicine, Mass General, Mount Sinai, Stanford Medicine, and UCLA Health.
Mika AI vs Vero, at a glance.
| Feature | Vero, try for free | Mika AI |
|---|---|---|
| Free plan | Vero, Free plan: yes10 actions a month, no time limit | Mika AI, Free plan: no30-day trial, then paid |
| iPhone and Android apps | Vero, iPhone and Android apps: yes | Mika AI, iPhone and Android apps: noWeb only |
| SOC 2 Type II | Vero, SOC 2 Type II: yesCertified | Mika AI, SOC 2 Type II: noWorking towards it (June 2025) |
| Monthly plan | Vero, Monthly plan: yes$89/month, cancel any time | Mika AI, Monthly plan: noBilled yearly |
| Languages | Vero, Languages: yes60+, up to 3 in one visit | 20+; only French and English mixed |
| Diagnosis and billing codes | Vero, Diagnosis and billing codes: yesICD-10-CM, CPT and HCPCS | Mika AI, Diagnosis and billing codes: yesDiagnostic and billing codes |
| Live visit audio never stored | Vero, Live visit audio never stored: yes | Mika AI, Live visit audio never stored: yesNever recorded |
Everything around the visit, in one workspace.
Scribe
The note is done before the patient leaves.
- Record, type, or upload
- Follows your template
- Understands 60+ languages
Shortness of Breath
Today 1:31 PM · SOAP note
Subjective
2-day history of shortness of breath and wheezing, worse in spring
No fever, no sick contacts, denies chest pain
Objective
T: 36.4°C, BP: 120/84 mmHg, HR: 88 bpm, RR: 24/min, O2 sat: 98% RA
Respiratory: Mild expiratory wheezes bilaterally, no crackles
Assessment
Asthma exacerbation
Plan
Care plan documented and reviewed
Referral for pulmonary function tests
Follow-up timing and return precautions documented
Does this patient’s chart change which guideline applies?
It may. Vero compares the chart context with the inclusion criteria and cautions in the current regional guideline. GINA
It separates points supported by comparative evidence from areas that still require clinical judgment. JAMA
- 1.GINAInternational evidence-based guideline
- 2.JAMASystematic review of comparative outcomes
- 3.NAEPPFocused update to clinical guidance
Which sources should I review for this clinical question?
Vero compares current regional guidance, summarizes where sources agree or differ, and keeps citations beside the answer. GINALancet
- -The relevant regional guideline and its publication date GINA
- -Areas of agreement and uncertainty across sources Lancet
- 1.GINAGlobal Strategy for Asthma Management and Prevention
- 2.TLAsthma: Seminar
Laboratory Requisition
Page 1 of 2Patient's name
Miguel Alvarez
Date of birth
Mar 14, 1985
Insurance member ID
XGH 4821 9307
Patient's telephone number
(312) 555-0182
Additional clinical information (e.g. diagnosis)
Type 2 diabetes, 6-month follow-up (E11.9)
Biochemistry
Where Vero wins.
On your phone
iPhone and Android apps that keep recording when the phone is locked. Mika AI runs in the browser only.
SOC 2 Type II certified
Audited security today. Mikata’s own security FAQ (June 2025) says it is still working towards SOC 2.
A free plan that stays
10 actions a month after the 7-day trial, no card needed. Mika AI has a 30-day trial, then paid plans only.
60+ languages
Up to three in one visit. Mika AI lists 20+ and mixes only French and English.